Clark Ian T

Clark Ian T is listed in filings as Director at Biomarin Pharmaceutical Inc. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to Biomarin Pharmaceutical Inc (BMRN), Kyverna Therapeutics, Inc. (KYTX), Guardant Health Inc (GH), and Olema Pharmaceuticals, Inc. (OLMA). The current snapshot covers public activity from Jun 17, 2024 to Jun 4, 2026. Reported amounts are shown as $176.8K to $5.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.